标题
Agomelatine for the treatment of generalized anxiety disorder
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 18, Issue 13, Pages 1373-1379
出版商
Informa UK Limited
发表日期
2017-07-22
DOI
10.1080/14656566.2017.1359257
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study
- (2017) Dan J. Stein et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder
- (2017) Massimiliano Buoli et al. Expert Opinion on Drug Metabolism & Toxicology
- Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder
- (2017) Stewart A. Shankman et al. JOURNAL OF CLINICAL PSYCHIATRY
- Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study
- (2017) Tsz-tai Chan et al. Psychogeriatrics
- Agomelatine-induced thrombocytopenic purpura, a possible new adverse effect
- (2017) Delphine Bourneau-Martin et al. THERAPIE
- Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study
- (2017) Tsz-tai Chan et al. Psychogeriatrics
- Is There a Role for Agomelatine in the Treatment of Anxiety Disorders? A Review of Published Data
- (2017) D. De Berardis et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice
- (2017) Vincent Martin et al. Scientific Reports
- Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients
- (2016) Gabriel Perlemuter et al. CNS DRUGS
- Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA)
- (2016) Ta-Chuan Yeh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders
- (2015) Alfredo Carlo Altamura et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacological treatment for generalized anxiety disorder in adults: an update
- (2015) Jennifer A Reinhold et al. EXPERT OPINION ON PHARMACOTHERAPY
- Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
- (2015) Domenico De Berardis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale
- (2015) Angel L Montejo et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Generalized Anxiety Disorder
- (2015) Murray B. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Valproic Acid–Induced Thrombocytopenia May Cause Wound Nonhealing in Individuals With Schizophrenia
- (2015) Yu-Ting Tseng et al. PSYCHOSOMATICS
- Role of Atypical Antipsychotics in the Treatment of Generalized Anxiety Disorder
- (2014) Rachel Hershenberg et al. CNS DRUGS
- Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
- (2014) Maximilian Gahr Current Neuropharmacology
- Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder
- (2014) Massimiliano Buoli et al. Expert Opinion on Drug Metabolism & Toxicology
- Agomelatine: a new option for treatment of depression?
- (2014) Chi-Un Pae EXPERT OPINION ON PHARMACOTHERAPY
- Cardiovascular adverse effects of newer antidepressants
- (2014) Rajnish Mago et al. Expert Review of Neurotherapeutics
- Evaluation of the Effects of Therapeutic and Supratherapeutic Doses of Agomelatine on the QT/QTc Interval
- (2014) Yves Donazzolo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Agomelatine in Generalized Anxiety Disorder
- (2014) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antidepressant-Induced Liver Injury: A Review for Clinicians
- (2013) Cosmin Sebastian Voican et al. AMERICAN JOURNAL OF PSYCHIATRY
- Agomelatine-induced gynaecomastia
- (2013) Hui Ling Tan AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder
- (2013) Bernardo Dell'Osso et al. Early Intervention in Psychiatry
- New approaches to the pharmacological management of generalized anxiety disorder
- (2013) Massimiliano Buoli et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
- (2013) Domenico De Berardis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Agomelatinin İndüklediği Makülopapüler Döküntü: Bir Olgu Sunumu
- (2013) Aslıhan OKAN İBİLOĞLU et al. Noropsikiyatri Arsivi-Archives of Neuropsychiatry
- Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
- (2013) Michele Fornaro et al. Neuropsychiatric Disease and Treatment
- Effect of Quetiapine and Norquetiapine on Anxiety and Depression in Major Psychoses Using a Pharmacokinetic Approach
- (2012) A. Carlo Altamura et al. CLINICAL DRUG INVESTIGATION
- Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study
- (2012) Cristina Dobrea et al. Expert Opinion On Drug Safety
- Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care
- (2012) Borwin Bandelow et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Agomelatine Prevents Relapse in Generalized Anxiety Disorder
- (2012) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Agomelatine-Induced Akathisia with Concomitant Duloxetine Medication: A Case Report
- (2012) C. Imboden et al. PHARMACOPSYCHIATRY
- Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder
- (2011) Alfredo Carlo Altamura et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Humanistic and economic burden of generalized anxiety disorder in North America and Europe
- (2011) Dennis A. Revicki et al. JOURNAL OF AFFECTIVE DISORDERS
- A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
- (2010) Michele Fornaro et al. Current Neuropharmacology
- Review: The importance of early symptom relief in antidepressant treatment: focus on agomelatine
- (2010) Raymond W Lam JOURNAL OF PSYCHOPHARMACOLOGY
- Can We Prevent Fatal Liver Failure under Valproate?
- (2010) M. M. Schmid et al. PHARMACOPSYCHIATRY
- Slow vs standard up-titration of paroxetine in the treatment of panic disorder: A prospective randomized trial
- (2010) Massimiliano Buoli et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
- (2010) Robert Howland Neuropsychiatric Disease and Treatment
- Extreme Creatine Phosphokinase Elevation in a 20-Year-Old Man Participating in a Clinical Trail of Major Depressive Disorder
- (2009) Thomas M. Shiovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system
- (2008) Luis San et al. EUROPEAN PSYCHIATRY
- Efficacy of Agomelatine in Generalized Anxiety Disorder
- (2008) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR
- (2008) Sidney H. Kennedy et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started